Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Thoracic Vertebrae | 1 | 2016 | 597 | 0.380 |
Why?
|
| Nerve Block | 1 | 2016 | 688 | 0.330 |
Why?
|
| Ultrasonography, Interventional | 1 | 2016 | 1502 | 0.300 |
Why?
|
| Mastectomy | 1 | 2016 | 1832 | 0.290 |
Why?
|
| Anesthesia, Epidural | 1 | 2016 | 233 | 0.110 |
Why?
|
| Postoperative Complications | 1 | 2016 | 15697 | 0.110 |
Why?
|
| Platelet-Derived Growth Factor | 3 | 2002 | 617 | 0.110 |
Why?
|
| Liver | 3 | 1998 | 7509 | 0.100 |
Why?
|
| Perfusion | 1 | 1996 | 1376 | 0.100 |
Why?
|
| Cold Temperature | 1 | 1995 | 780 | 0.100 |
Why?
|
| Neovascularization, Physiologic | 3 | 2002 | 1336 | 0.080 |
Why?
|
| Gene Transfer Techniques | 3 | 2002 | 1204 | 0.070 |
Why?
|
| Urinary Retention | 1 | 2007 | 106 | 0.070 |
Why?
|
| Naltrexone | 1 | 2007 | 317 | 0.060 |
Why?
|
| Naloxone | 1 | 2007 | 369 | 0.060 |
Why?
|
| Surgical Flaps | 3 | 2002 | 1669 | 0.050 |
Why?
|
| Narcotic Antagonists | 1 | 2007 | 583 | 0.050 |
Why?
|
| Fibroblasts | 3 | 2002 | 4090 | 0.050 |
Why?
|
| Urinary Bladder | 1 | 2007 | 1166 | 0.050 |
Why?
|
| Piperidines | 1 | 2007 | 1650 | 0.040 |
Why?
|
| Incidence | 1 | 2016 | 21392 | 0.040 |
Why?
|
| Rats | 7 | 2002 | 23711 | 0.040 |
Why?
|
| Cells, Cultured | 5 | 2002 | 18957 | 0.030 |
Why?
|
| Rats, Inbred Lew | 3 | 2002 | 1154 | 0.030 |
Why?
|
| Ischemia | 1 | 2002 | 1893 | 0.030 |
Why?
|
| Esophageal Motility Disorders | 1 | 1993 | 48 | 0.030 |
Why?
|
| Albumins | 1 | 1995 | 575 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2016 | 54303 | 0.020 |
Why?
|
| Jejunum | 1 | 1993 | 471 | 0.020 |
Why?
|
| Analgesics, Opioid | 1 | 2007 | 3763 | 0.020 |
Why?
|
| Stress, Physiological | 1 | 1998 | 1398 | 0.020 |
Why?
|
| Cytoskeleton | 1 | 1995 | 1167 | 0.020 |
Why?
|
| Cryopreservation | 1 | 1995 | 717 | 0.020 |
Why?
|
| Transfection | 1 | 1998 | 5781 | 0.020 |
Why?
|
| Microtubules | 1 | 1995 | 1072 | 0.020 |
Why?
|
| Adenocarcinoma, Mucinous | 1 | 1993 | 517 | 0.020 |
Why?
|
| Receptors, Purinergic | 1 | 1988 | 66 | 0.020 |
Why?
|
| Gastrectomy | 1 | 1993 | 679 | 0.020 |
Why?
|
| Actins | 1 | 1995 | 2049 | 0.020 |
Why?
|
| Diazepam | 1 | 1988 | 215 | 0.020 |
Why?
|
| Miosis | 1 | 2007 | 9 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2016 | 80372 | 0.020 |
Why?
|
| Esophagus | 1 | 1993 | 1023 | 0.020 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2007 | 202 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1995 | 3682 | 0.020 |
Why?
|
| Urination | 1 | 2007 | 202 | 0.020 |
Why?
|
| Rats, Sprague-Dawley | 1 | 1996 | 8158 | 0.020 |
Why?
|
| Cell Survival | 1 | 1995 | 5797 | 0.020 |
Why?
|
| Middle Aged | 3 | 2016 | 220352 | 0.010 |
Why?
|
| Adult | 3 | 2016 | 219994 | 0.010 |
Why?
|
| Lymphoma | 1 | 1993 | 1898 | 0.010 |
Why?
|
| Stomach Neoplasms | 1 | 1993 | 1423 | 0.010 |
Why?
|
| DNA | 1 | 1996 | 7233 | 0.010 |
Why?
|
| Corpus Striatum | 1 | 1988 | 1233 | 0.010 |
Why?
|
| Infusions, Intravenous | 1 | 2007 | 2234 | 0.010 |
Why?
|
| Muscle Contraction | 1 | 2007 | 1201 | 0.010 |
Why?
|
| Mitotic Index | 1 | 2002 | 161 | 0.010 |
Why?
|
| Animals | 7 | 2002 | 167963 | 0.010 |
Why?
|
| Cross-Over Studies | 1 | 2007 | 2061 | 0.010 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1998 | 3804 | 0.010 |
Why?
|
| Female | 5 | 2016 | 391270 | 0.010 |
Why?
|
| Capillaries | 1 | 2002 | 744 | 0.010 |
Why?
|
| Ketone Bodies | 1 | 1998 | 76 | 0.010 |
Why?
|
| Epigastric Arteries | 1 | 1998 | 92 | 0.010 |
Why?
|
| Glucagon | 1 | 1998 | 532 | 0.010 |
Why?
|
| Abdomen | 1 | 2002 | 1130 | 0.010 |
Why?
|
| Adenocarcinoma | 1 | 1993 | 6315 | 0.010 |
Why?
|
| Retroviridae | 1 | 1998 | 850 | 0.010 |
Why?
|
| Epinephrine | 1 | 1998 | 791 | 0.010 |
Why?
|
| Interleukin-1 | 1 | 1998 | 1249 | 0.010 |
Why?
|
| Humans | 3 | 2016 | 760621 | 0.010 |
Why?
|
| Esophagostomy | 1 | 1993 | 6 | 0.010 |
Why?
|
| Time Factors | 1 | 1995 | 40165 | 0.010 |
Why?
|
| Peristalsis | 1 | 1993 | 59 | 0.010 |
Why?
|
| Jejunostomy | 1 | 1993 | 59 | 0.010 |
Why?
|
| Anastomosis, Roux-en-Y | 1 | 1993 | 86 | 0.010 |
Why?
|
| Double-Blind Method | 1 | 2007 | 12427 | 0.010 |
Why?
|
| Reference Values | 1 | 1998 | 4925 | 0.010 |
Why?
|
| Manometry | 1 | 1993 | 453 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1998 | 1803 | 0.010 |
Why?
|
| Flunitrazepam | 1 | 1988 | 20 | 0.010 |
Why?
|
| Radioligand Assay | 1 | 1988 | 366 | 0.000 |
Why?
|
| Interleukin-6 | 1 | 1998 | 3215 | 0.000 |
Why?
|
| Rats, Inbred Strains | 1 | 1988 | 2094 | 0.000 |
Why?
|
| Male | 4 | 2007 | 359744 | 0.000 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 1998 | 4357 | 0.000 |
Why?
|
| Multivariate Analysis | 1 | 1998 | 12159 | 0.000 |
Why?
|
| Receptors, GABA-A | 1 | 1988 | 621 | 0.000 |
Why?
|
| Research Design | 1 | 1998 | 6180 | 0.000 |
Why?
|
| Treatment Outcome | 1 | 2007 | 65017 | 0.000 |
Why?
|
| Gene Expression Regulation | 1 | 1998 | 11903 | 0.000 |
Why?
|
| Disease Models, Animal | 1 | 1998 | 18137 | 0.000 |
Why?
|
| Sensitivity and Specificity | 1 | 1993 | 14660 | 0.000 |
Why?
|
| Hippocampus | 1 | 1988 | 3738 | 0.000 |
Why?
|
| Electroencephalography | 1 | 1988 | 6189 | 0.000 |
Why?
|
| Sleep | 1 | 1988 | 4751 | 0.000 |
Why?
|
| Cerebral Cortex | 1 | 1988 | 5761 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1993 | 39261 | 0.000 |
Why?
|
| Aged | 1 | 1993 | 169152 | 0.000 |
Why?
|
Concepts
(99)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(5)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_
Physical Neighbors
People whose addresses are nearby this person.
_